ArticleJournal of experimental & clinical cancer research : CR2022

Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer.

Dipranjan Laha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.